Large Study Ties Chronic Insomnia to Faster Cognitive Decline and Dementia Markers
The findings spotlight biological changes that strengthen the case for randomized trials on whether treating insomnia can curb risk.
Overview
- Following 2,750 adults aged 50 and older for about 5.5 years, Mayo Clinic researchers found chronic insomnia was linked to a 40% higher likelihood of developing mild cognitive impairment or dementia.
- Participants were classified using medical-record diagnoses of insomnia at least twice a month apart, a definition that identified 16% of the cohort.
- Insomnia coupled with shorter-than-usual sleep corresponded to worse cognitive performance equivalent to roughly four extra years of aging and to higher amyloid plaques plus more white-matter hyperintensities on brain scans.
- The measured effect of chronic insomnia on decline was comparable in size to the risk from carrying the ApoE4 genetic variant, which itself remained a strong predictor of faster deterioration.
- The study found no clear benefit or harm from commonly used sleep medications, evidence for newer orexin blockers remains small and short-term, and CBT for insomnia improves sleep yet has not been proven to prevent dementia.